NYSEAMERICAN : APUS

Apimeds Pharmaceuticals US, Inc. — Key statistics

Healthcare · Drug Manufacturers - Specialty & Generic · United Arab Emirates

Last price 3.1 USD (Oct 30, 2026, 9:31 AM EDT) · Market cap 4.68M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	4.54M
Enterprise Value	n/a

Dates

Measure	Value
Earnings Date	Nov 16, 2026
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	n/a
Shares Outstanding	1.51M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.38%
Owned by Institutions (%)	2.82%
Float	725,942

Ratios

Measure	Value
PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Evratios

Measure	Value
EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financialposition

Measure	Value
Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financialefficiency

Measure	Value
Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-78.61%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Measure	Value
Income Tax	n/a
Effective Tax Rate	n/a

Stockprice

Measure	Value
Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.70
200-Day Moving Average	10.77
Relative Strength Index (RSI)	42.43
Average Volume (20 Days)	5,171,536

Shortselling

Measure	Value
Short Interest	73,009
Short Previous Month	10,346
Short % of Shares Out	4.84%
Short % of Float	10.06%
Short Ratio (days to cover)	0.01

Incomestatement

Measure	Value
Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balancesheet

Measure	Value
Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cashflow

Measure	Value
Operating Cash Flow	-5.21M
Capital Expenditures	-35,909
Depreciation & Amortization	1,721
Net Borrowing	250,100
Free Cash Flow	-5.24M
FCF Per Share	-$3.47

Margins

Measure	Value
Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	-29.09%
Shareholder Yield	-29.09%
Earnings Yield	n/a
FCF Yield	-115.42%

Analystforecasts

Measure	Value
Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stocksplits

Measure	Value
Last Split Date	Jul 24, 2026
Split Type	Reverse
Split Ratio	1:10

Scores

Measure	Value
Altman Z-Score	n/a
Piotroski F-Score	n/a

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a